Literature DB >> 3007840

Protection against bovine leukemia virus infection in sheep by active and passive immunization.

Y Kono, K Arai, H Sentsui, S Matsukawa, S Itohara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3007840     DOI： 10.1292/jvms1939.48.117

Source DB:  PubMed          Journal:  Nihon Juigaku Zasshi        ISSN： 0021-5295


× No keyword cloud information.
  7 in total

1.  Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.

Authors:  M Merza; J Söber; B Sundquist; I Toots; B Morein
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins.

Authors:  O Orlik; G A Splitter
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.

Authors:  O Orlik; J Ban; J Hlavaty; C Altaner; R Kettmann; D Portetelle; G A Splitter
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.

Authors:  M H Gatei; H M Naif; S Kumar; D B Boyle; R C Daniel; M F Good; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 5.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

6.  Preparation of a cell line persistently infected with maedi/visna virus and production of viral antigens.

Authors:  Kazuya Suzuki; Keisuke Oguma; Hiroshi Sentsui
Journal:  J Vet Med Sci       Date:  2016-10-30       Impact factor: 1.267

7.  Isolation of maedi/visna virus from a sheep in Japan.

Authors:  Keisuke Oguma; Chiaki Tanaka; Ryo Harasawa; Atsushi Kimura; Jun Sasaki; Masanobu Goryo; Hiroshi Sentsui
Journal:  J Vet Med Sci       Date:  2013-10-18       Impact factor: 1.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.